New CEO, different direction for ICID
'Exciting opportunity' for centre's Borody
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 20/08/2010 (5734 days ago), so information in it may no longer be current.
The International Centre for Infectious Diseases has hired a new chief executive officer.
John Borody, who has been the CEO at the Addictions Foundation of Manitoba for the last 11 years, will take over the helm of the Winnipeg organization Sept. 27.
"It sounded like an exciting opportunity," Borody told the Free Press Thursday. "It’s a dynamic organization."
ICID is in the middle of an organizational shift, having lost out on a bid to build an $88-million HIV vaccine production facility to produce small amounts of research vaccines for use in clinical trials. It was to be the signature project of the Canadian HIV Vaccine Initiative.
ICID reportedly spent $750,000 putting together its bid for the facility and saw the project as its lifeline for the future. One source close to the project told the Free Press ICID had spent the money to make sure it’s bid could not be beaten.
But after a three-year process that saw four candidates shortlisted for the project, the Public Health Agency of Canada decided not to go ahead with the facility after all. It cited a study by the Gates Foundation which said there no longer was a need for a pilot scale manufacturing facility.
Numerous HIV researchers disagreed but PHAC and the Gates Foundation moved their money elsewhere.
Borody said he sees this as an opportunity to help take ICID in new directions.
"I look at it as a revitalization of the organization," he said.
In an emailed statement Thursday, ICID board chairman Lorne Babiuk said Borody’s appointment will "solidify the management team and ensure that we achieve our mission."
ICID had been working with an acting CEO — Heather Medwick — for the last year. Former CEO Terry Duguid resigned a year ago when he announced he was running for the federal Liberals in Winnipeg South.
ICID was created in 2004 with a founding investment from the federal government and a mandate to improve Canada’s contribution to the global battle against infectious diseases. Among its functions are training and professional development courses in biosafety and lab management, as well as pulling together large-scale research projects on infectious diseases.
Much of its funding comes from the federal government. Last year it received over $1.6 million, mostly from public health.
mia.rabson@freepress.mb.ca